Free shipping on orders over $150
Botulinum Toxin 100iu research vial

peptides

Botulinum Toxin 100iu

Botulinum neurotoxin type A (100 units) is a cleavage-specific SNAP-25 protease used in neuromuscular junction research, studying presynaptic acetylcholine release inhibition and its duration.

Research-observed benefits

  • SNAP-25 cleavage studies
  • Neuromuscular junction models
  • Dermal research applications
  • Well-characterized potency

Findings reported in in-vitro / preclinical research literature. Not therapeutic claims.

CAS Number

Purity

99%+

Molecular Formula

Stock

120 units

Order type

Purchase option

Quantity

1

Total

$60

For in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Storage at -20°C recommended for lyophilized peptides.

Botulinum Toxin 100iu — Full Research Breakdown

Tailored information for researchers. All content is for in-vitro / preclinical research context only — not medical advice.

Mechanism of Action

Botulinum neurotoxin type A cleaves SNAP-25, a SNARE protein required for acetylcholine vesicle fusion at the presynaptic neuromuscular junction, producing reversible chemical denervation.

How It Helps

The definitive research tool for studying presynaptic transmitter release, muscle-tone modulation, and reinnervation kinetics — activity is local, dose-proportional, and reverses as terminals sprout.

Half-Life

Local action, not systemic; functional effect persists roughly 3–4 months

Onset of Effects

Measurable effect at 2–5 days, peak near 14 days.

Storage

Lyophilized: 2–8°C. Reconstituted: 2–8°C, use within 24 hours. Do not shake.

Stacks Well With

  • GHK-Cu (dermal research)
  • Glow Blend (skin-endpoint studies)

Research-Observed Side Effects

  • Local weakness beyond target site
  • Bruising
  • Headache
  • Transient ptosis in facial models

Translational Cautions

  • Neuromuscular disorders (myasthenia gravis, ALS) in translation
  • Infection at the study site
  • Aminoglycoside co-exposure

Research Highlights

  • SNAP-25 cleavage mechanism confirmed across mammalian preparations.
  • Potency is unit-defined by mouse LD50 assay and is not interchangeable between products.
  • Effect duration correlates with axonal sprouting and terminal recovery timelines.

Researcher FAQ